Revenue visibility is strong, but 2026 EBITDA growth slows sharply after exceptional 2025 execution.
| Quarter | Q4 FY25 |
|---|---|
| Call date | 2026-02-25 |
| Length | 44 minutes |
| EPS | $1.08 |
| EPS consensus | $0.72 |
| Revenue | $1.0B |
| Revenue consensus | $879.6M |
What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.
Other quarters: Q2 FY25
All ECG earnings ยท Back to ECG overview
Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.